Official 2024 U.S. DOL Form 5500 summary for Cerevel Therapeutics LLC (Cerevel Therapeutics LLC 401(k) Plan · EIN 83-1334174 · PN 001): $43.62M net assets, 333 active participants, and $1.55 per $10,000 (1.55 bps).
| Plan Sponsor | Cerevel Therapeutics LLC |
|---|---|
| Filing Identifier | Cerevel Therapeutics LLC 401(k) Plan · EIN 83-1334174 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (MA) |
| Asset-Size Peer Cohort | $25M-$100M |
| Plan Net Assets (2024) | $43.62M |
| Active Participants | 333 |
| Direct Admin Fee Rate | $1.55 per $10,000 (1.55 bps) |
| Cohort Peer Median | $19.23 per $10,000 (19.23 bps) |
| Primary Recordkeeper / Provider | Vanguard |
| Schedule H Line 4a Remittance | Timely Employer Remittance (0 reported on Line 4a) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI